Caspofungin therapy for Aspergillus lung infection in a boy with chronic granulomatous disease

Pediatric Infectious Disease Journal

Volumn 22, Issue 2, 2003, Pages 199-200

  Sallmann, Svea ^a   Heilmann, Antje ^a   Heinke, Frank ^a   Kerkmann, Marie Louise ^a   Schuppler, Markus ^a   Hahn, Gabriele ^a   Gahr, Manfred ^a   Rösen Wolff, Angela ^a   Roesler, Joachim ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Caspofungin; Chronic granulomatous disease; Invasive aspergillosis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; CANDIDAS; CASPOFUNGIN; COTRIMOXAZOLE; ITRACONAZOLE; ANTIINFECTIVE AGENT; CYCLOPEPTIDE; PEPTIDE;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; ASPERGILLUS RESTRICTUS; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; HUMAN; INFECTION SENSITIVITY; LIVER ABSCESS; LUNG FIBROSIS; LUNG INFECTION; LYMPHADENOPATHY; MALE; NEUTROPENIA; NEUTROPHIL; PERIANAL ABSCESS; PRIORITY JOURNAL; THORAX RADIOGRAPHY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; FOLLOW UP; ISOLATION AND PURIFICATION; LUNG MYCOSIS; OPPORTUNISTIC INFECTION; TREATMENT OUTCOME;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; LUNG DISEASES, FUNGAL; MALE; OPPORTUNISTIC INFECTIONS; PEPTIDES; PEPTIDES, CYCLIC; TREATMENT OUTCOME;

EID: 85047687561     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000050460.55352.dd     Document Type: Article

References (15)

1. Curnutte JT. Chronic granulomatous disease: the solving of a clinical riddle at the molecular level. Clin Immunol Immunopathol 1993;67:S2-15.
2. Babior BM, Kipnes RS, Curnutte JT. Biological defense mechanisms: the production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 1973;52:741-4.
3. Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine 2000;79:155-69.
4. Villanueva A, Arathoon EG, Gotuzzo E, Berman RS, DiNubile MJ, Sable CA. A randomized double blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis. Clin Infect Dis 2001;33:1529-35.
5. Groll AH, Walsh TJ. Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections. Expert Opin Invest Drugs 2001;10:1545-58.
6. Keating GM, Jarvis B. Caspofungin. Drugs 2001;61:1121-31.
7. Roesler J, Heyden S, Burdelski M, et al. Uncommon missense and splice mutations and resulting biochemical phenotypes in German patients with X-linked chronic granulomatous disease. Exp Hematol 1999;27:505-11.
8. -/-mice: implications for fungal pathogenicity and host defense in chronic granulomatous disease. J Clin Invest 1998;101:1843-50.
9. Segal BH, DeCarlo ES, Kwon-Chung KJ, Malech HL, Gallin JI, Holland SM. Aspergillus nidulans infection in chronic granulomatous disease. Medicine 1998;77:345-54.
10. Hajdu R, Thompson R, Sundelof JG, et al. Preliminary animal pharmacokinetics of the parenteral antifungal agent MD-0991 (L-743, 872). Antimicrob Agents Chemother 1997;41:2339-44.
11. Petraitiene R, Petraits V, Groll AH, et al. Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia. Antimicrob Agents Chemother 2002;46:12-23.
12. Arikan S, Lozano-Chiu M, Paetznick V, Rex JH. In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp. Antimicrob Agents Chemother 2002;46:245-7.
13. Hoang A. Caspofungin acetate: an antifungal agent. Am J Health Syst Pharm 2001;58:1206-14.
14. Denning DW. Echinocandins and pneumocandins: a new antifungal class with a novel mode of action. J Antimicrob Chemother 1997;40:611-14.
15. Fournier I, Barwicz J, Tancrede P. The structuring effects of amphotericin B on pure and ergosterol- or cholesterol-containing dipalmitoylphosphatidylcholine bilayers: a differential scanning calorimetry study. Biochim Biophys Acta 1998;1373:76-86.